Eve Wellness Expands AI Breast Screening Services
Eve Wellness is making a significant impact in the breast cancer screening landscape with the opening of its second clinic in Walnut Creek, California on October 15, 2026. This expansion coincides perfectly with Breast Cancer Awareness Month, highlighting the urgent need for accessible breast cancer screening.
Founded in October 2022 in San Francisco, Eve Wellness is pioneering direct-to-consumer breast cancer screening clinics, utilizing state-of-the-art 3D Ultrasound and FDA-approved AI image analysis technology. The clinic in Walnut Creek offers women a quick, comfortable, and efficient screening experience, allowing them to obtain a physician-read ultrasound in just 20 minutes without any need for a doctor's referral.
The service is priced at $349, with results provided within 48 hours. Notably, Eve Wellness accepts Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA) for payments, making it financially accessible for many women. The introduction of this clinic is part of Eve's broader mission to provide advanced breast screening options to communities across the United States.
Reflecting on this expansion, Brendan Foley, co-founder and president of Eve Wellness, stated, "As we expand Eve's locations, we continue to strive for making advanced breast screening more accessible to women everywhere. Our patients have informed us throughout our journey, helping us create an experience that is comfortable, efficient, and tailored to their needs. The Walnut Creek location is just the beginning as we aim to extend our services to many cities across the country."
Since its inception, Eve Wellness has screened over 4,000 patients in its San Francisco location alone. Among those who shared follow-up results, 41 individuals received a diagnosis of cancer, with 16 diagnosed under the age of 40. This highlights the importance of having accessible screening options, especially for younger women.
Patients like Anisha Malik have relayed their positive experiences with Eve Wellness. Malik, who had a family history of breast cancer, was diagnosed with stage one cancer at the age of 37. She expressed immense gratitude for the timely and efficient care provided by Eve Wellness, affirming, "I just wake up with gratitude every day. Having that ultrasound at Eve was crucial for fast-tracking my care."
Eve Wellness utilizes the advanced GE HealthCare's Invenia™ ABUS system, the first FDA-approved ultrasound dedicated to supplemental screening for women with dense breast tissue. Each screening is further enhanced with QView Medical's FDA-approved QVCAD® AI tool, which assists in breast cancer detection.
Dr. Ian Grady, Medical Director at Eve Wellness, emphasized the significance of the AI software used in screenings, stating, "The AI technology has progressed dramatically over the years. In the time I've been implementing this technology, I've yet to find a breast cancer that it wasn't capable of detecting."
In this context, Bob Wang, founder and CEO of QView Medical, noted the critical role of the combined technologies, explaining, "For millions of women with dense breast tissue, traditional mammograms may not provide adequate insights. By incorporating advanced imaging with AI insights, we give women the reassurance and clarity they need while also empowering clinicians to detect potential issues earlier."
The opening of the Walnut Creek clinic marks a vital step in Eve Wellness's growth strategy. It is strategically located at 1844 San Miguel Drive near Broadway Plaza, and appointments are now available for interested patients. Eve Wellness's clinics focus on identifying areas needing further evaluation, referring patients for diagnostic imaging and biopsies as necessary, ensuring comprehensive care.
As the fight against breast cancer continues, Eve Wellness stands as a beacon of hope, striving to transform breast cancer screening and make it more accessible to women everywhere. For more information and to schedule appointments, visit
Eve Wellness's official website.